Literature DB >> 21874434

Resection of lung metastases from hepatocellular carcinoma after living donor liver transplantation: report of two cases.

Junichi Togashi1, Yasuhiko Sugawara, Taku Aoki, Sumihito Tamura, Junichi Kaneko, Jun Nakajima, Atsushi Sano, Norihiro Kokudo.   

Abstract

Hepatocellular carcinoma (HCC) recurrence after liver transplantation is associated with a poor prognosis; nonetheless, we report two cases of long-term survival after resection of pulmonary metastatic lesions following living donor liver transplantation (LDLT). The intervals between LDLT and pulmonary resection for the metastatic lesion were 24 months and 30 months, respectively. Regular checking of tumor markers and prompt workup for early detection may contribute to the resectability of such metastatic lesions. These cases suggest that resection of a solitary metastatic lesion in the lung from HCC after liver transplantation may be a feasible treatment for selected patients.

Entities:  

Mesh:

Year:  2011        PMID: 21874434     DOI: 10.1007/s00595-010-4487-6

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  24 in total

1.  Surgical resection of pulmonary metastases after orthotopic liver transplantation for hepatocellular carcinoma.

Authors:  Hernan A Bazan; Kirk A McMurtry; Paul F Waters; Swan N Thung
Journal:  Transplantation       Date:  2002-03-27       Impact factor: 4.939

2.  Surgical resection of resectable thoracic metastatic hepatocellular carcinoma after liver transplantation.

Authors:  Chong Zhang; Jian Rao; Zhengliang Tu; Yiming Ni
Journal:  J Thorac Cardiovasc Surg       Date:  2009-01-31       Impact factor: 5.209

3.  Long-term survival after report resection of pulmonary metastases from hepatocellular carcinoma: report of two cases.

Authors:  Toru Nakamura; Taizo Kimura; Yasuhiko Umehara; Kenji Suzuki; Kazuya Okamoto; Takuya Okumura; Sei Morizumi; Toshiki Kawabata; Akira Komiyama
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

4.  Current status of organ transplantation in Japan and worldwide.

Authors:  Norio Yoshimura; Hideaki Okajima; Hidetaka Ushigome; Seisuke Sakamoto; Masato Fujiki; Masahiko Okamoto
Journal:  Surg Today       Date:  2010-05-23       Impact factor: 2.549

Review 5.  Tumor surveillance-what can and should be done? Screening for recurrence of hepatocellular carcinoma after liver transplantation.

Authors:  John P Roberts
Journal:  Liver Transpl       Date:  2005-11       Impact factor: 5.799

6.  Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan.

Authors:  Satoru Todo; Hiroyuki Furukawa
Journal:  Ann Surg       Date:  2004-09       Impact factor: 12.969

7.  Pattern and management of recurrent hepatocellular carcinoma after liver transplantation.

Authors:  E Regalia; L R Fassati; U Valente; A Pulvirenti; I Damilano; G Dardano; F Montalto; J Coppa; V Mazzaferro
Journal:  J Hepatobiliary Pancreat Surg       Date:  1998

8.  Surgical treatment of hepatocellular carcinoma: comparison of resection and transplantation.

Authors:  Yasuhiko Sugawara; Norihiro Kokudo
Journal:  Oncology       Date:  2008-12-17       Impact factor: 2.935

Review 9.  Systemic therapy of hepatocellular carcinoma: are we making progress?

Authors:  Patricia Roxburgh; T R Jeffry Evans
Journal:  Adv Ther       Date:  2008-11       Impact factor: 3.845

10.  Pulmonary resection of metastatic hepatocellular carcinoma after liver transplantation.

Authors:  Michael J Bates; Emily Farkas; David Taylor; P Michael McFadden
Journal:  Ann Thorac Surg       Date:  2008-02       Impact factor: 4.330

View more
  2 in total

Review 1.  Progress in the treatment of pulmonary metastases after liver transplantation for hepatocellular carcinoma.

Authors:  Zhan-Wang Xiang; Lin Sun; Guo-Hong Li; Rakesh Maharjan; Jin-Hua Huang; Chuan-Xing Li
Journal:  World J Hepatol       Date:  2015-09-18

Review 2.  Pharyngeal metastasis following living-donor liver transplantation for hepatocellular carcinoma: a case report and literature review.

Authors:  Taiji Tohyama; Katsunori Sakamoto; Kei Tamura; Taro Nakamura; Jota Watanabe; Hiroyuki Wakisaka; Yasutsugu Takada
Journal:  World J Surg Oncol       Date:  2020-05-28       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.